Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics symbols : Aqst save search
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Published: 2024-04-12 (Crawled : 20:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
| Email alert
Add to watchlist
neurology for meeting therapeutics study
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
EBS | $2.005 7.8% 440K
|
Health Technology
|
| O: -4.85%
H: 2.18%
C: -9.8%
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: -3.85%
H: 2.35%
C: -2.82%
biotech therapeutics
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 0.0%
H: 3.2%
C: -4.57%
offering therapeutics
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
Published: 2024-03-20 (Crawled : 02:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: -13.86%
H: 2.17%
C: -2.07%
million offering therapeutics
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
Published: 2024-03-19 (Crawled : 20:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: -13.86%
H: 2.17%
C: -2.07%
offering therapeutics
Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
Published: 2024-03-14 (Crawled : 21:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 3.05%
H: 14.23%
C: 12.57%
fda update meeting therapeutics study
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $48.89 1.22% 5.1M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.275 6.25% 2.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | $17.51 0.06% 1.2M
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $23.735 -0.11% 620K
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: -2.15%
H: 26.59%
C: 22.68%
business year update therapeutics financial results
Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
Published: 2024-02-21 (Crawled : 13:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 0.38%
H: 1.35%
C: -5.64%
conference report business therapeutics financial results
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting
Published: 2024-02-15 (Crawled : 13:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 0.0%
H: 2.61%
C: 1.49%
meeting therapeutics
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
Published: 2024-01-30 (Crawled : 13:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: -0.41%
H: 0.41%
C: -2.86%
conference therapeutics
Aquestive Therapeutics Doses First Patient in Phase 3 Pivotal Clinical Study Evaluating Pharmacokinetics and Pharmacodynamics of Anaphylm™ (epinephrine) Sublingual Film
Published: 2023-12-05 (Crawled : 13:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 1.21%
H: 1.2%
C: -4.4%
first therapeutics study
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for Anaphylm™ at American College of Allergy Asthma and Immunology (ACAAI) Annual Meeting
Published: 2023-11-10 (Crawled : 13:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 1.75%
H: 0.57%
C: -3.45%
positive immunology meeting therapeutics
Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-06 (Crawled : 22:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 1.84%
H: 4.82%
C: 3.01%
business update therapeutics financial results
Aquestive Therapeutics Completes $45 Million Debt Refinancing
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
MS | News 0 d | $90.86 0.66% 4.7M
|
Finance
|
| O: 0.87%
H: 0.0%
C: 0.0%
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 0.65%
H: 2.58%
C: -7.1%
therapeutics
Aquestive Therapeutics to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 6 and Host Conference Call on November 7 at 8:00 a.m. ET
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 0.0%
H: 9.93%
C: 3.97%
conference report business therapeutics financial results
Aquestive Therapeutics Provides Business Update
Published: 2023-10-09 (Crawled : 12:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: -2.26%
H: 7.69%
C: 1.54%
business update therapeutics
Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual Film
Published: 2023-09-20 (Crawled : 13:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 7.84%
H: 8.04%
C: 3.64%
therapeutics
Aquestive Therapeutics Receives FDA Acceptance of New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film in Pediatric Patients and Assignment of Prescription Drug User Fee Act (PDUFA) Date
Published: 2023-09-11 (Crawled : 12:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: -0.67%
H: 11.41%
C: 5.37%
fda drug application therapeutics
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
Published: 2023-08-23 (Crawled : 12:00) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 0.0%
H: 5.68%
C: 1.7%
therapeutics
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.